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	 Condensation	of	cyanoacetamide	3	with	cycloalkanones	and	elemental	sulfur	in	the	presence
of	 morpholine	 yielded	 the	 bisthiophenes	 4	 and	 5.	 Also,	 its	 (3)	 condensation	 with
terphthalaldehyde	or	coupling	with	p‐phenylenedidiazonium	chloride	afforded	compound	13
and	 14,	 respectively.	 Furthermore,	 cyanoacetylation	 of	 compound	 4	 or	 5	 afforded	 the
cyanoacetamides	 6	 and	 7,	 respectively.	 Knoevenagel	 condensation	 of	 compound	 7	 with
aromatic	aldehyde	afforded	the	arylidenes	10,	11	and	coumarin	12,	respectively.	Treatment
of	compound	3	with	CS2	in	DMF/KOH	followed	by	alkylation	reaction	with	ethyl	bromoacetate
afforded	 the	 triester	 derivative	 16,	 which	 gave	 3‐aminothiophene	 17	 upon	 heating	 in
DMF/TEA.	 Moreover,	 refluxing	 of	 compound	 23	 with	 α‐haloketones	 afforded	 3‐
aminothiophenes	24	and	25.	Identity	of	newly	synthesized	compounds	was	established	by	the
spectral	data	and	novel	compounds	were	evaluated	as	antioxidant	agents.	
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1.	Introduction	
	
Substituted	 2‐aminothiophenes	 are	 important	 interme‐
diates	 in	 the	synthesis	of	a	variety	of	agrochemicals,	dyes	and	
pharmacologically	 active	 compounds	 [1‐3].	 The	 most	
convergent	 and	 well‐established	 classical	 approach	 for	 the	
preparation	 of	 2‐aminothiophenes	 is	 Gewald’s	 method	 [4],	
which	involves	multicomponent	condensation	of	a	ketone	with	
an	 activated	 nitrile	 and	 elemental	 sulfur	 in	 the	 presence	 of	
morpholine	 as	 a	 catalyst.	 3‐(3,5‐Dimethyl‐1H‐pyrazol‐1‐yl)‐3‐
oxopropanenitrile	 (2)	 is	 a	 very	 handy	 and	 cheap	 cyano	
acetylation	 reagent,	which	was	 first,	 synthesized	 and	 introdu‐
ced	in	common	practice	in	the	late	1950s	by	Ried	and	Scheimer	
[5].	 It	was	 successfully	applied	 for	 the	 synthesis	of	various	N‐
alkyl	and	N‐aryl	cyanoacetamides	[6].	Recently,	Gorobets	et	al.	
[7],	 prepare	 a	 series	 from	 cyanoacetamides	 via	 refluxing	 of	 2	
with	the	appropriate	amines	in	toluene.	More	recently,	we	used	
compound	2	for	preparation	of	ethyl	2‐(2‐cyano‐acetylamino)‐
4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxylate,	3	[8].	
On	 the	 other	 hand,	 oxidative	 stress	 results	 in	 oxidative	
alteration	of	biological	macromolecules	such	as	lipids,	proteins	
and	nucleic	acids.	 It	 is	 considered	 to	play	a	pivotal	 role	 in	 the	
pathogenesis	 of	 aging	 and	 degenerative	 diseases	 [9‐11].	 In	
order	 to	 cope	with	 an	 excess	 of	 free	 radicals	 produced	 upon	
oxidative	 stress,	 human	 bodies	 have	 developed	 sophisticated	
mechanisms	 for	 maintaining	 redox	 homeostasis.	 These	
protective	mechanisms	 include	scavenging	or	detoxification	of	
reactive	 oxygen	 species	 (ROS),	 blocking	 ROS	 production,	
sequestration	 of	 transition	 metals,	 as	 well	 as	 enzymatic	 and	
nonenzymatic	antioxidant	defenses	produced	in	the	body,	that	
is,	 endogenous	 [12,13]	 and	 others	 supplied	 with	 the	 diet,	
namely,	 exogenous	 ones.	 Among	 them,	 dietary	 polyphenols	
have	been	widely	studied	for	their	strong	antioxidant	capacities	
and	other	properties	by	which	cell	functions	are	regulated	[14,	
15].	 Recently,	 thiophenecarbohydrazide,	 thienopyrazole	 and	
thienopyrimidine	 derivatives	 showed	 interesting	 biological	
properties	 including	antioxidant	and	antitumor	activities	 [16].	
In	view	of	the	above	result	we	use	herein	3	as	a	building	block	
for	the	construction	of	poly‐thiophene	ring	systems	in	order	to	
evaluate	their	antioxidant	activity.	
	
2.	Experimental	
	
2.1.	Instrumentations	
	
All	melting	 points	 are	 determined	 on	 Gallenkamp	 electric	
melting	point	apparatus	(uncorrected).		
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Scheme	1
	
	
Thin	layer	chroma‐tography	(TLC)	analysis	was	carried	out	
on	silica	gel	60F254	precoated	aluminum	sheets.	The	IR	spectra	
were	 recorded	 (KBr)	 on	 a	 Mattson	 5000	 FTIR	 Spectrophoto‐
meter	at	the	Microanalytical	Unit,	Faculty	of	Science,	Mansoura	
University	1H/13C	NMR	spectra	were	recorded	at	400	and	100	
MHz,	 respectively,	 on	 a	Bruker	 400	NMR	 spectrometer	 in	 the	
indicated	 solvents	 using	 TMS	 as	 an	 internal	 reference,	 at	 the	
Georgia	 State	 University,	 Atlanta,	 Georgia,	 USA.	 The	 mass	
spectra	 (EI)	 were	 recorded	 on	 Kratos	 MS	 equipment	 at	 the	
Microanalytical	 Center,	 Cairo	 University,	 Egypt.	 Elemental	
analyses	 (C,	H	 and	N)	were	 carried	out	 at	 the	Microanalytical	
Center	 of	 Cairo	 University,	 Egypt.	 Biological	 activities	 were	
carried	 out	 at	 Pharmacognosy	 Department,	 Faculty	 of	
Pharmacy,	 Mansoura	 University,	 Mansoura,	 Egypt.	 Ethyl	 2‐
amino‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxy	 late	 (1)	
[17],	 ethyl	 2‐[(cyanoacetyl)amino]‐4,5,6,7‐tetrahydro‐1‐benzo	
thiophene‐3‐carboxylate	 (3)	 [8]	 and	 (Z)‐ethyl	 2‐(2‐cyano‐3‐
mercapto‐3‐(phenylamino)acrylamido)‐4,	 5,	 6,	 7‐tetrahydro	
benzo[b]thiophene‐3‐carboxylate	(23)	[8]	were	reported	in	the	
literature	
	
2.2.	Synthesis	
	
2.2.1.	Reaction	of	ethyl	2‐[(cyanoacetyl)	amino]‐4,5,6,7‐tetra	
hydro‐1‐benzothiophene‐3‐carboxylate	(3)	with	cyclic	
ketones	and	elemental	sulfur		
	
General	 procedure:	 Morpholine	 (0.33	 mL,	 3.9	 mmol),	
elemental	sulfur	(0.141	g,	4.4	mmol)	and	cyclopentanone	(0.34	
g,	4	mmol)	or	cyclohexanone	(0.39	g,	4	mmol)	were	added	to	a	
solution	of	 compound	3	 (1.17	 g,	 4	mmol)	 in	 ethanol	 (20	mL).	
The	reaction	mixture	was	refluxed	at	60‐80	°C	for	6	h	and	left	
to	 stand	 at	 room	 temperature.	 The	 separated	 crystalline	
product	 was	 filtered,	 dried	 and	 recrystallized	 from	
ethanol:benzene	mixture	(3:2,	v:v)	to	give	compounds	4	and	5,	
respectively	(Scheme	1).	
Ethyl	 2‐{[(2‐amino‐5,6‐dihydro‐4H‐cyclopenta[b]thien‐3‐yl)	
carbonyl]amino}‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxy	
late	(4):	Color:	White	powder.	Yield:	1.39	g,	89%.		M.p.:	241	°C.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	3415,	3305,	3261	 (NH2,	NH),	1673,	1616	
(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	1.30	(t,	3H,	J	=	6.8	
Hz,	 CH3),	 1.71‐1.73	 (m,	 4H,	 C5‐2H,	 C6‐2H,	 cyclohexane	
skeleton),	 2.37‐2.40	 (m,	 2H,	 C5‐2H,	 cyclopentane	 skeleton),	
2.58‐2.70	(m,	6H,	C4‐2H,	C7‐2H,	cyclohexane	skeleton	and	C4‐
2H,	 cyclopentane	 skeleton),	 3.09‐3.18	 (m,	 2H,	 C6‐2H,	
cyclopentane	skeleton),	4.28	(q,	2H,	 J	=	6.8	Hz,	CH2O),	7.53	(s,	
2H,	NH2),	11.04	(s,	1H,	NH‐CO).	13C	NMR	(100	MHz,	DMSO‐d6,	δ,	
ppm):	 168.7,	 165.3,	 161.3,	 147.0,	 137.6,	 129.8,	 125.3,	 120.3,	
110.0,	100.9,	59.9,	29.28,	25.7,	23.4,	22.3,	22.2,	13.8.	EI‐MS	(m/z	
(%)):	392	(M++2,	3.13),	390	(M+,	19.9),	344	(3.3),	300	(0.8),	225	
(62.9),	 178	 (100),	 166	 (73.0),	 150	 (68.2),	 138	 (26.7),	 122	
(54.9),	 109	 (65.9),	 104	 (86.8),	 90	 (32.2),	 76	 (5.0),	 65	 (48.2).	
Anal.	calcd.	for	C19H22N2O3S2:	C,	58.44;	H,	5.68;	N,	7.17.	Found:	
C,	58.40;	H,	5.64;	N,	7.14%.	
Ethyl	 2‐{[(2‐amino‐4,	 5,	 6,	 7‐tetrahydro‐1‐benzothien‐3‐yl)	
carbonyl]amino}‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxy	
late	(5):	Color:	White	powder.	Yield:	1.45	g,	90%.		M.p.:	200	°C.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	4421,	3397,	3299	 (NH,	NH2),	 1681,	1623	
(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	1.30	(t,	3H,	J	=	6.8	
Hz,	 CH3),	 1.73‐1.76	 (m,	 8H,	 2C5‐2H,	 2C6‐2H	 ,	 cyclohexane	
skeleton),	 2.50‐2.59	 (m,	 4H,	 2C4‐2H,	 cyclohexane	 skeleton),	
2.72‐2.78	(m,	4H,	2C7‐2H	cyclohexane	skeleton),	4.28	(q,	2H,	J	=	
6.8	Hz,	CH2O),	7.34	(s,	2H,	NH2),	11.10	(s,	1H,	NH‐CO).	13C	NMR	
(100	MHz,	DMSO‐d6,	δ,	ppm):	165.1,	162.4,	161.6,	147.0,	129.9,	
128.3,	 125.3,	 116.6,	 110.1,	 105.1,	 59.8,	 25.9,	 25.7,	 22.3,	 22.2,	
13.8.	EI‐MS	(m/z	 (%)):	406	(M++2,	2.0),	405	(M++1,	4.47),	404	
(M+,	 14.0),	 325	 (3.4),	 225	 (100),	 180	 (67.2),	 151	 (17.4),	 91	
(15.5),	68	(1.5).	Anal.	calcd.	for	C20H24N2O3S2:	C,	59.38;	H,	5.98;	
N,	6.92.	Found:	C,	59.43;	H,	6.05;	N,	6.97%.		
	
2.2.2.	Reaction	of	2‐aminothiophene	derivatives	(4)	or	(5)	
with	3‐(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)‐3‐oxopropanenitrile	
(2)		
	
General	 procedure:	 A	 mixture	 of	 compound	 4	 (5.40	 g,	 14	
mmol)	or	5	(5.66	g,	14	mmol)	and	compound	2	[18]	(2.28	g,	14	
mmol)	 in	 dioxane	 (20	mL),	was	 refluxed	 for	 5	 h.	 The	 solvent	
was	evaporated	under	vacuum	and	the	residue	was	crystallized	
form	ethanol/DMF	(5:1,	v:v)	mixture	to	give	compounds	6	and	
7,	respectively	(Scheme	1).		
Ethyl	 2‐[({2‐[(cyanoacetyl)amino]‐5,	 6‐dihydro‐4H‐cyclo	
penta[b]thien‐3‐yl}carbonyl)amino]‐4,5,6,7‐tetrahydro‐1‐benzo	
thiophene‐3‐carboxylate	(6):	Color:	White	powder.	Yield:	4.99	g,	
78%.		M.p.:	227	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3284,	3216	(NH),	2253	
(CN),	1670,	1627	(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
1.32	 (t,	 3H,	 J	 =	 7.2	 Hz,	 CH3),	 1.72‐1.74	 (m,	 4H,	 C5‐2H,	 C6‐2H,	
cyclohexane	 skeleton),	 2.44‐2.47	 (m,	 2H,	 C5‐2H,	 cyclopentane	
skeleton),	2.63‐2.82	(m,	6H,	C4‐2H,	C7‐2H,	cyclohexane	skeleton	
and	 C4‐2H,	 cyclopentane	 skeleton),	 3.09‐3.20	 (m,	 2H,	 C6‐2H,	
cyclopentane	skeleton),	4.23	(s,	2H,	CH2CN),	4.30	(q,	2H,	J	=	7.2	
Hz,	CH2O),	11.40	(s,	1H,	NH‐CO),	11.64	(s,	1H,	NH‐CO).	13C	NMR	
(100	MHz,	DMSO‐d6,	δ,	ppm):	166.2,	160.4,	149.1,	147.3,	137.8,	
134.0,	130.4,	126.7,	116.0,	112.2,	111.1,	60.3,	29.0,	 28.0,	27.6,	
25.7,	23.5,	22.2,	22.1,	13.8.	EI‐MS	 (m/z	 (%)):	459	 (M++2,	0.6),	
457	(M+,	1.5),	295	(0.3),	251	(0.6),	233	(12.3),	225	(26.8),	205	
(5.4),	 178	 (37.6),	 165	 (82.1),	 151	 (17.1),	 104	 (13.9),	 91	 (9.7),	
67	 (100).	 	 Anal.	 calcd.	 for	 C22H23N3O4S2:	 C,	 57.75;	 H,	 5.07;	 N,	
9.18.	Found:	C,	57.53;	H,	5.01;	N,	9.22%.	
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Scheme	2	
	
	
Ethyl	2‐[({2‐[(cyanoacetyl)amino]‐4,	5,	6,	7‐tetrahydrobenzo	
[b]thien‐3‐yl}carbonyl)amino]‐4,	 5,	 6,	 7‐tetrahydro‐1‐benzothio	
phene‐3‐carboxylate	 (7):	 Color:	 White	 powder.	 Yield:	 4.95	 g,	
75%.	M.p.:	237	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3293,	3212	(NH),	2260	
(CN),	1670,	1623	(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
1.31	(t,	3H,	 J	=	6.8	Hz,	CH3),	1.74‐1.80	(m,	8H,	2C5‐2H,	2C6‐2H,	
cyclohexane	 skeleton),	 2.62‐2.80	 (m,	 8H,	 2C4‐2H,	 2C7‐2H	
cyclohexane	skeleton),	4.08	(s,	2H,	CH2CN),	4.31	(q,	2H,	J	=	6.8	
Hz,	CH2O),	11.37	(s,	1H,	NH‐CO),	11.46	(s,	1H,	NH‐CO).	13C	NMR	
(100	MHz,	DMSO‐d6,	δ,	ppm):	165.3,	160.8,	160.3,	145.7,	130.4,	
129.2,	128.4,	126.4,	117.3,	115.0,	111.7,	 60.2,	25.8,	23.6,	23.5,	
22.2,	 22.1,	 22.0,	 13.8.	 EI‐MS	 (m/z	 (%)):	 473	 (M++2,	 0.8),	 471	
(M+,	 7.2),	 247	 (8.6),	 225	 (100),	 206	 (10.3),	 179	 (52.8),	 151	
(21.4),	 91	 (13.3),	 68	 (50.5).	 Anal.	 calcd.	 for	 C23H25N3O4S2:	 C,	
58.58;	H,	5.34;	N,	8.91.	Found:	C,	58.53;	H,	5.30;	N,	8.87%.	
	
2.2.3.	Reaction	of	ethyl‐2‐[({2‐[(cyanoacetyl)amino]	4,5,6,7‐
tetrahydrobenzo	[b]thien‐3‐yl}carbonyl)amino]‐4,5,6,7‐
tetrahydro‐1‐benzothiophene‐3‐carboxylate	(7)	with	cyclic	
ketones	and	elemental	sulfur	
	
General	 procedure:	 Morpholine	 (0.33	 mL),	 elemental	
sulphur	(0.141	g,	4.4	mmol)	and	cyclohexanone	(0.4	g,	4	mmol)	
or	cyclopentanone	(0.34	g,	4	mmol)	were	added	to	solution	of	
compound	7	(1.88	g,	4	mmol)	in	a	mixture	of	ethanol:DMF	(4:1,	
v:v,	 25	mL).	 The	 reaction	mixture	was	 heated	 under	 reflux	 at	
60‐80oC	 for	 6	 h	 and	 left	 to	 cool	 to	 room	 temperature.	 The	
separated	 crystalline	 product	 was	 filtered,	 dried,	 and	
recrystallized	from	DMF:ethanol	(2:3,	v:v)	to	give	compounds	8	
and	9,	respectively	(Scheme	2).	
Ethyl‐2‐{[(2‐{[(2‐amino‐5,	 6‐dihydro‐4H‐cyclopenta[b]thien‐
3‐yl)carbonyl]amino}‐5,	 6‐dihydro‐4H‐cyclopenta[b]‐thien‐3‐yl)	
carbonyl]amino}‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxy	
late	(8):	Color:	White	powder.	Yield:	1.50	g,	66%.	M.p.:	235	°C.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	3409,	3286,	3261	 (NH,	NH2),	1668,	1616	
(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	1.37	(t,	3H,	J	=	6.8	
Hz,	 CH3),	 1.76‐1.85	 (m,	 8H,	 2C5‐2H,	 2C6‐2H,	 cyclohexane	
skeleton),	 2.56‐2.87	 (m,	 10H,	 C5‐2H,	 cyclopentane	 skeleton,	
2C4‐2H,	2C7‐2H,	cyclohexane	skeleton),	3.05‐3.35	(m,	4H,	C4‐2H,	
C6‐2H,	 cyclopentane	 skeleton),	 4.33	 (q,	 2H,	 J	 =	 6.8	 Hz,	 CH2O),	
8.20	 (s,	 2H,	NH2),	 11.52	 (s,	1H,	NH‐CO),	12.44	 (s,	 1H,	NH‐CO).	
13C	 NMR	 (100	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 170.5,	 165.5,	 160.9,	
147.9,	 145.1,	 134.6,	 134.2,	 130.7,	 132.0,	 122.9,	 120.8,	 119.1,	
118.0,	 116.0,	 115.2,	 112.3,	 64.5,	 31.4,	 31.3,	 29.1,	 28.2,	 27.8,	
25.7,	24.1,	24.0,	23.9,	14.4.		EI‐MS	(m/z	(%)):	570	(M++1,	0.12),	
569	 (M+,	 0.13),	 430	 (3.4),	 390	 (10.7),	 384	 (17.7),	 370	 (14.9),	
344	(6.42),	225	(73.5),	205	(26.8),	178	(100),	165	(76.5),	150	
(64.3),	138	(25.1),	122	(38.1),	109	(29.2),	103	(27.2),	90	(25.5),	
77	 (34.1),	64	(27.5).	Anal.	 calcd.	 for	C28H31N3O4S3:	C,	59.02;	H,	
5.48;	N,	7.38.	Found:	C,	58.98;	H,	5.45;	N,	7.40%.	
Ethyl‐2‐{[(2‐{[(2‐amino‐4,	5,	6,	7‐tetrahydro‐1‐benzothien‐3‐
yl)carbonyl]amino}‐4,5,6,	7‐tetrahydro‐1‐benzothien‐3‐yl)carbon	
yl]amino}‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxylate	
(9):	Color:	White	powder.	Yield:	1.61	g,	69%.	M.p.:	255	°C.	FT‐IR	
(KBr,	ν,	cm‐1):	3419,	3282,	3265	(NH,	NH2),	1660,	1610	(C=O).	
1H	NMR	 (400	MHz,	DMSO‐d6,	 δ,	 ppm):	 1.35	 (t,	 3H,	 J	 =	 6.8	Hz,	
CH3),	 1.71‐1.82	 (m,	 12H,	 3C5‐2H,	 3C6‐2H,	 cyclohexane	
skeleton),	 2.77‐2.87	 (m,	 12H,	 3C4‐2H,	 3C7‐2H,	 cyclohexane	
skeleton	),	4.33	(q,	2H,	J	=	6.8	Hz,	CH2O),	8.20	(s,	2H,	NH2),	11.62	
(s,	 1H,	 NH‐CO),	 11.80	 (s,	 1H,	 NH‐CO).	 EI‐MS	 (m/z	 (%)):	 584	
(M++1,	0.2),	483	(0.2,	M+),	465	(0.3),	405	(0.9),	385	(0.4),	357	
(0.2),	314	(0.3),	258	(1.7),	224	(8.4),	179	(100),	150	(67.0),	123	
(61.2),	 128	 (2.1),	 117	 (39.1),	 91	 (29.6),	 76	 (41.2),	 50	 (38.1).	
Anal.	calcd.	for	C29H33N3O4S3:	C,	59.66;	H,	5.70;	N,	7.20.	Found:	
C,	59.61;	H,	5.72;	N,	7.18%.	
	
2.2.4.	Reaction	of	ethyl‐2‐[({2‐[(cyanoacetyl)amino]‐4,5,6,7‐
tetrahydrobenzo[b]thien‐3‐yl}carbonyl)amino]‐4,5,6,7‐tetra	
hydro‐1‐benzothiophene‐3‐carboxylate	(7)	with	aromatic	
aldehydes	
	
General	 procedure:	 A	mixture	 of	 compound	7	 (1.17	 g,	 2.5	
mmol),	4‐(dimethylamino)	benzaldehyde	(0.37	g,	2.5	mmol),	4‐
(piperidin‐1‐yl)benzaldehyde	 (0.47g,	 2.5	mmol),	 or	 2‐hydroxy	
benzaldehyde	(0.31	g,	2.5	mmol)	in	ethanol	(15	mL)	containing	
piperidine	(0.2	mL)	was	stirred	at	80	°C	for	4	h.	The	separated	
crystals	was	 filtered,	 dried	 and	washed	with	 hot	DMF	 to	 give	
compounds	10‐12,	respectively	(Scheme	2).	
Ethyl	 2‐({[2‐({(2E)‐2‐cyano‐3‐[4‐(dimethylamino)phenyl]	
prop‐2‐enoyl}amino)‐4,	 5,	 6,	 7‐tetrahydro‐1‐benzothien‐3‐yl]	
carbonyl}amino)‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxy	
late	(10):	Color:	Red	needle	crystals.	Yield:	1.43	g,	95%.	M.p.:	>	
320	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3293,	 3183	 (2NH),	 2196	 (CN),	
1688,	 1614	 (C=O).	 EI‐MS	 (m/z	 (%)):	 605	 (M++3,	 29.4),	 604	
(M++2,	35.3),	255	(100),	180	(70.6),	179	(76.5),	156	(52.9),	107	
(29.4),	 98	 (35.3),	 77	 (70.6).	 Anal.	 calcd.	 for	 C32H34N4O4S2:	 C,	
63.76;	H,	5.69;	N,	9.29.	Found:	C,	63.69;	H,	5.66;	N,	9.31%.	
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Ethyl‐2‐({[2‐({(2E)‐2‐cyano‐3‐[4‐(piperidin‐1‐yl)phenyl]	
prop‐2‐enoyl}amino)‐4,5,6,	 7‐tetrahydro‐1‐benzothien‐3‐yl]	
carbonyl}amino)‐4,5,6,	 7‐tetrahydro‐1‐benzothiophene‐3‐
carboxylate	(11):	Color:	Red	crystals.	Yield:	1.52	g,	95%.		M.p.:	
306	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3446	 (br,	 NH),	 2191(CN),	 1671,	
1631	(C=O),	1606	(C=N).	EI‐MS	(m/z	(%)):	597	(M+‐OEt,	18.5),	
417	 (48.1),	 355	 (33.3),	 239	 (29.6),	 174	 (100),	 128	 (18.5),	 90	
(14.8),	 66	 (37.0),	 51	 (18.5).	 Anal.	 calcd.	 for	 C35H38N4O4S2:	 C,	
65.39;	H,	5.96;	N,	8.72.	Found:	C,	65.41;	H,	5.93;	N,	8.70.	
Ethyl	 2‐{[(2‐{[(2‐imino‐2H‐chromen‐3‐yl)carbonyl]amino}‐4,	
5,	 6,	 7‐tetrahydro‐1‐benzothien‐3‐yl)carbonyl]amino}‐4,	 5,	 6,	 7‐
tetrahydro‐1‐benzothiophene‐3‐carboxylate	 (12):	 Color:	 Yellow	
powder.	Yield:	 1.28	g,	 89%.	M.p.:	 260	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	
3413,	 3340,	 3255	 (NH),	 1670,	 1623	 (C=O).	 EI‐MS	 (m/z	 (%)):	
568	(M+	 ‐7,	0.21),	404	[M+‐3‐(carbonyliminocoumarine),	0.32],	
384	(M+,	0.4),	358	(0.5),	224	(12.9),	179	(100),	164	(11.6),	151	
(42.8),	134	(12.3),	123	(20.4),	117	(36.6),	97	(23.3),	86	(41.6),	
74	(31.4),	50	(49.8).	Anal.	 calcd.	 for	C30H29N3O5S2:	C,	62.59;	H,	
5.08;	N,	7.30.	Found:	C,	62.53;	H,	5.03;	N,	7.34%.	
	
2.2.5.	Synthesis	of	ethyl	2‐((E)‐2‐cyano‐3‐(4‐((E)‐2‐cyano‐3‐
(3‐(ethoxycarbonyl)‐4,5,6,	‐tetrahydrobenzo‐[b]thiophen‐2‐
ylamino)‐3‐oxoprop‐1‐enyl)phenyl)acrylamido)‐4,5,6,7‐
tetrahydrobenzo‐[b]thiophene‐3‐carboxylate	(13)	
	
A	mixture	of	compound	3	(0.73	g,	2.5	mmol)	and	terphthal	
aldehyde	 (0.17	 g	 1.25	 mmol)	 in	 ethanol	 (15	 mL)	 containing	
piperidine	(0.2	mL)	was	stirred	at	80	°C	for	4	h.	The	separated	
crystals	was	 filtered,	dried	and	 crystallized	 from	DMF:ethanol	
(4:1,	 v:v)	 mixture	 to	 give	 compound	 13	 (Scheme	 3).	 Color:	
Yellowish	green	powder.	Yield:	0.56	g,	77%.	M.p.:	239	°C.	FT‐IR	
(KBr,	ν,	cm‐1):	3184,	(NH),	2195	(CN),	1729,	1677,	1621	(C=O).	
1H	NMR	(DMSO‐d6,	δ,	ppm):	1.34	(m,	6H,	2CH3),	1.75‐1.82	(m,	
8H,	2C5‐2H,	2C6‐2H,	 cyclohexane	 skeleton	 ),	 2.82‐3.12	 (m,	8H,	
2C4‐2H,	 2C7‐2H,	 cyclohexane	 skeleton),	 4.42	 (m,	 4H,	 2CH2O),	
7.70‐8.0	 (m,	 6H,	 Ar‐H,	 2CH=),	 11.45	 (s,	 1H,	 NH‐CO),	 11.75	 (s,	
1H,	NH‐CO).	EI‐MS	 (m/z	 (%)):	679	 (M+‐3,	0.1),	 543	 (0.2),	 499	
(0.2),	453	(0.2),	404	(0.3),	384	(1.2),	359	(7.8),	336	(19.3),	290	
(8.9),	246	(21.5),	224	(27.4),	205	(33.4),	178	(70.0),	150	(91.3),	
126	(43.9),	122	(72.9),	111	(82.8),	90(60.0),	83(72.1),	68	(100).	
Anal.	calcd.	for	C36H34N4O6S2:	C,	63.32;	H,	5.02;	N,	8.21.	Found:	
C,	63.41;	H,	5.06;	N,	8.23%.	
	
2.2.6.	Synthesis	of	ethyl‐(E)‐2‐cyano‐2‐(2‐(4‐((E)‐2‐cyano‐1‐
(3‐(ethoxycarbonyl)‐4,5,6,7‐tetrahydrobenzo[b]thiophen‐2‐
ylacetamido)hydrazono)phenylhydrazono)‐N‐(4,5,6,7‐tetra	
hydrobenzo	[b]thiophen‐2‐yl)acetamido‐3‐	carboxylate	(14)	
	
To	 a	 well	 stirred	 cooled	 solution	 of	 p‐phenylenediamine				
(0.27	g,	2.5	mmol)	in	conc.	HCl	(3	mL),	a	solution	of	NaNO2	(0.4	
g,	 5.8	 mmol	 in	 5	 mL	 H2O)	 was	 added	 dropwise.	 The	 above	
cooled	 diazonium	 salt	 solution	 was	 added	 slowly	 to	 a	 well	
stirred	solution	of	2	(1.46	g,	5	mmol)	in	pyridine	(20	mL).	The	
reaction	mixture	 was	 stirred	 for	 2	 h.	 The	 crude	 product	 was	
filtered	 off,	 dried	 and	 recrystallize	 from	 DMF:EtOH	 (5:2,	 v:v)	
mixture	 to	 give	 compound	 14	 (Scheme	 3).	 Color:	 Scarlet	 red	
crystals.	Yield:	1.57	g,	88%.	 	M.p.:	305	°C.	FT‐IR	(KBr,	ν,	cm‐1):	
3218,	3166	 (NH),	2220,	 (CN),	1666,	1625	 (C=O),	 1488	 (N=N).	
1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	1.38‐1.41	(m,	6H,	2CH3),	
1.76‐1.82	(m,	8H,	2C5‐2H,	2C6‐2H,	cyclohexane	skeleton	),	2.70‐
2.93	 (m,	8H,	2C4‐2H,	2C7‐2H,	 cyclohexane	skeleton),	 4.41‐4.43	
(m,	4H,	2CH2O),	7.93‐8.44	(m,	4H,	Ar‐H),	10.45	(s,	1H,	NH‐CO),	
10.65	 (s,	 1H,	 NH‐CO),	 12.45	 (br,	 1H,	 NH=N),	 12.54	 (br,	 1H,	
NH=N).	EI‐MS	(m/z	(%)):	723	(M++1/2H2O,	0.1),	513	(M+,	0.2),	
467	 (0.6),	 436	 (0.8),	 396	 (5.5),	 292	 (10.1),	 246	 (28.7),	 225	
(27.5),	 206	 (91.4),	 178	 (100),	 150	 (65.0),	 121	 (44.3),	 115	
(38.0),	 104	 (31.9),	 90	 (65.5),	 67	 (65.3),	 64	 (52.9).	Anal.	 calcd.	
for	C34H34N8O6S2:	C,	57.13;	H,	4.79;	N,	15.68.	Found:	C,	57.18;	H,	
4.73;	N,	15.62%.	
	
2.2.7.	Synthesis	of	ethyl	2‐(2‐cyano‐3,3‐bis(2‐ethoxy‐2‐oxo	
ethylthio)acrylamido)‐4,5,6,7‐tetrahydrobenzo[b]thiophene	
‐3‐carboxylate	(16)	
	
To	 a	 cold	 suspension	 of	 KOH	 (1.16	 g,	 20	 mmole)	 in	 dry	
dimethylformamide	(25	mL)	were	added	the	nitrile	derivative	
3	(1.45	g,	5	mmole)	subsequently	carbon	disulphide	(1.14	g,	15	
mmol)	slowly	dropwise	under	stirring	over	a	period	of	15	min.	
while	 the	 temperature	of	 the	mixture	was	maintained	at	5‐10	
°C.	The	mixture	was	stirred	at	room	temperature	for	12	h.	Then	
cooled	again	at	0	°C,	ethyl	bromoacetate	(1.67	g,	10	mmol)	was	
added	 dropwise	 over	 a	 period	 of	 10	min	 and	 left	 to	 stand	 at	
room	 temperature	 for	24	h.	The	mixture	was	poured	onto	 ice	
cold‐water.	The	resulting	precipitate	was	filtered	off,	dried	and	
crystallized	 from	 ethanol:DMF	 (1:5,	 v:v)	 mixture	 to	 give	
compound	16	 (Scheme	4).	 Color:	 Yellow	 sheet	 crystals.	 Yield:	
2.19	g,	81%.	M.p.:	178	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3140	(NH),	2170	
(CN),	1729,	1677,	1621	(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	
ppm):	1.14	(t,	3H,	J	=	6.8	Hz,	CH3),	1.25	(t,	3H,	J	=	6.8	Hz,	CH3),	
1.28	 (t,	 3H,	 J	 =	 6.8	 Hz,	 CH3),	 1.75‐1.78	 (m,	 4H,	 C5‐2H,	 C6‐2H,	
cyclohexane	 skeleton),	 2.65‐2.79	 (m,	 4H,	 C4‐2H,	 C7‐2H,	
cyclohexane	skeleton	),	3.17	(br,	4H,	2CH2),	4.07	(q,	2H,	J	=	6.8	
Hz,	CH2O),	4.18	(q,	2H,	J	=	6.8	Hz,	CH2O),	4.31	(q,	2H,	J	=	6.8	Hz,	
CH2O),	 12.66	 (s,	 1H,	NH‐CO).	 13C	NMR	 (100	MHz,	DMSO‐d6,	 δ,	
ppm):	 169.4,	 166.5,	 166.4,	 163.9,	 145.9,	 143.1,	 132.7,	 127.9,	
115.2,	 61.4,	 61.0,	 60.2,	 37.1,	 36.7,	 25.6,	 23.6,	 22.2,	 22.1,	 13.8,	
and	13.6.	EI‐MS	(m/z	(%)):	540	(M+,	0.8),	529	(3.9),	424	(35.3),	
385	 (2.8),	 366	 (5.2),	 338	 (2.0),	 224	 (20.6),	 205	 (39.5),	 177	
(76.4),	 150	 (69.0),	 134	 (63.9),	 119	 (52.1),	 108	 (81.9),	 101	
(69.9),	 83(76.3),	 76	 (100),	 63	 (87.3).	 Anal.	 calcd.	 for	
C23H29N2O7S3:	C,	51.09;	H,	5.22;	N,	5.18.	Found:	51.15;	H,	5.18;	
N,	5.19%.	
		
2.2.8.	Synthesis	of	ethyl	2‐(4‐amino‐2‐(2‐ethoxy‐2‐oxoethyl	
thio)‐5‐(ethoxycarbonyl)	thiophene‐3‐carboxamido)‐4,5,6,7‐
tetrahydrobenzo[b]thiophene‐3‐carboxylate	(17)	
	
A	mixture	of	compound	16	(0.54	g,	1.0	mmol)	and	TEA	(0.2	
mL)	in	DMF	(15	mL)	was	stirred	at	140	°C.		
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Scheme	4
	
	
The	 mixture	 was	 cooled,	 poured	 into	 cooled	 water,	 the	
separated	 crystals	 was	 filtered,	 dried	 and	 crystallize	 from	
DMF:EtOH	(1:2,	v:v)	mixture	to	give	compound	17	(Scheme	4).	
Color:	 Brown	 powder.	 Yield:	 0.36	 g,	 66%.	M.p.:	 192	 °C.	 FT‐IR	
(KBr,	 ν,	 cm‐1):	3411,	3280,	3261	 (NH,	NH2),	1714,	1677,	1614	
(C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	1.21‐1.28	(m,	9H,	
3CH3),	 1.74‐1.77	 (m,	 4H,	 C5‐2H,	 C6‐2H,	 cyclohexane	 skeleton),	
2.65‐2.79	(m,	4H,	C4‐2H,	C7‐2H,	cyclohexane	skeleton),	3.16	(s,	
2H,	 CH2),	 4.26‐4.31	 (m,	 6H,	 J	 =	 6.8	 Hz,	 3CH2O),	 5.08	 (br,	 2H,	
NH2),	 12.03	 (s,	1H,	NHCO).	EI‐MS	 (m/z	 (%)):	541	 (M++1,	0.2),	
525	(3.5),	464	(1.1),	422	(1.9),	390	(1.7),	377	(35.2),	346	(2.6),	
238	 (5.3),	 225	 (30.2),	 206	 (19.3),	 177	 (35.2),	 165	 (10.1),	 150	
(46.5),	120	(89.1),	108	(95.3),	93	(38.7),	90	(45.1),	77	(100),	68	
(41.7),	57	(86.6).	Anal.	calcd.	for	C23H28N2O7S3:	C,	51.09;	H,	5.22;	
N,	5.18.	Found:	51.05;	H,	5.26;	N,	5.15%.	
	
2.2.9.	Synthesis	of	ethyl	2‐(2‐cyano‐2‐(4‐methyl‐3‐phenyl	
thiazol‐2(3H)‐ylidene)acetamido)‐4,5,6,7‐tetrahydrobenzo‐
[b]thiophene‐3‐carboxylate	(19)	and	ethyl	2‐(2‐cyano‐2‐(4‐
oxo‐3‐phenylthiazolidin‐2‐ylidene)acetamido)‐4,5,6,7‐tetra	
hydrobenzo[b]thiophene‐3‐carboxylate	(20)	
	
To	a	cold	suspension	of	finely	divided	KOH	(0.11	g,	2	mmol)	
in	 dry	 dimethylformamide	 (10	 mL),	 the	 cyanoacetamide	
derivative	 3	 (0.58	 g,	 2	 mmol)	 followed	 by	 phenyl	 isothio	
cyanate	(0.27	g,	2	mmol)	was	added.	The	mixture	was	stirred	at	
room	 temperature	 for	 12	 h,	 and	 then	 cooled	 again	 to	 5‐0	 °C,	
treated	 with	 the	 chloroacetone	 (0.18	 g,	 2	 mmol)	 or	 ethyl	
bromoacetate	 (0.24	 g,	 2	 mmol)	 and	 left	 to	 stand	 at	 room	
temperature	 for	 24	 h,	 the	 mixture	 was	 poured	 into	 ice	 cold	
water.	 The	 resulting	 precipitate	 was	 filtered	 off,	 dried	 and	
crystallized	 from	 DMF:	 ethanol	 (5:2,	 v:v)	 mixture	 to	 afford	
compounds	19	and	20,	respectively	(Scheme	5).		
Ethyl	 2‐{[(2Z)‐2‐cyano‐2‐(4‐methyl‐3‐phenyl‐1,	 3‐thiazol‐
2(3H)‐ylidene)acetyl]amino}‐4,	 5,	 6,	 7‐tetrahydro‐1‐benzothio	
phene‐3‐carboxylate	 (19):	 Color:	 Pale	 yellow	 powder.	 Yield	
0.59	g,	63%.	M.p.:	206	°C.	(Lit.		[8],	205	°C).	
Ethyl	2‐(2‐cyano‐2‐(4‐oxo‐3‐phenylthiazolidin‐2‐ylidene)acet	
amido)‐4,	5,	6,	7‐tetrahydrobenzo[b]thiophene‐3‐carboxylate	
(20):	Color:	Brown	powder.	Yield:	0.51	g,	55%.	M.p.:	>	320	°C.	
(Lit.		[8]	>	320	°C).	
	
2.2.10.	Reaction	of	ethyl	2‐{[(2E)‐3‐anilino‐2‐cyano‐3‐
mercaptoprop‐2‐enoyl]amino}‐4,5,6,7‐tetrahydro‐1‐benzo	
thiophene‐3‐carboxylate	(23)	with	α‐halogen	carbonyl	
compounds		
	
Chloroacetone	(0.18	g,	2	mmol)	or	ethyl	bromoacetate	was	
added	 in	 solution	 containing	 ethanol	 (10	 mL),	 triethylamine	
(0.2	 mL)	 and	 compound	 23	 (0.86	 g,	 2	 mmole).	 The	 reaction	
mixture	 was	 refluxed	 for	 3	 h.	 The	 obtained	 product	 after	
addition	 of	 water	 was	 filtered,	 dried	 and	 crystallized	 from	
ethanol:benzene	 (1:	 3,	 v:v)	 to	 give	 compounds	 24	 and	 25,	
respectively	(Scheme	5).	
Ethyl	 2‐{[(5‐acetyl‐4‐amino‐2‐anilino‐3‐thienyl)	 carbonyl]	
amino}‐4,	 5,	 6,	 7‐tetrahydro‐1‐benzothiophene‐3‐carboxylate	
(24):		Color:	Brown	crystals.	Yield	0.67	g,	69%.	M.p.:	230	°C.	FT‐
IR:	3234	(NH,	NH2,	br),	1671,	1610	(C=O).	 1H	NMR	(400	MHz,	
DMSO‐d6,	δ,	ppm):	1.21	(t,	3H,	J	=	7.2	Hz,	CH3),	1.74‐1.90	(m,	4H,	
C5‐2H,	 C6‐2H),	 2.10	 (s,	 3H,	 CH3),	 2.63‐2.77	 (m,	 4H,	 C4‐2H,	 C7‐
2H),	4.42	(q,	2H,	J	=	7.2	Hz,	CH2O),	7.1‐7.5	(m,	8H,	NH2,	NH,	Ar‐
H),	11.82	(s,	1H,	NH‐CO).	EI‐MS	(m/z	(%)):	484	(M++1,	8.9),	451	
(6.9),	437	(7.6),	259	(15.0),	242	(22.0),	225	(41.0),	216	(47.9),	
178	 (100),	 150	 (66.1),	 143	 (37.7),	 121	 (41.5),	 116	 (37.0),	 90	
(36.7),	 76	 (64.9),	 50	 (25.8).	 Anal.	 calcd.	 For	 C24H25N3O4S2:	 C,	
59.61;	H,	5.21;	N,	8.69.	Found:	C,	59.56;	H,	5.15;	N,	8.75%.		
Ethyl	 2‐(3‐amino‐2‐(ethoxycarbonyl)‐5‐(phenylamino)thio	
phene‐4‐carboxamido)‐4,	5,	6,	7‐tetrahydrobenzo[b]thiophene‐3‐
carboxylate	(25):	Color:	Brown	crystals.	Yield	0.81	g,	79%.	M.p.:	
283	 oC.	 FT‐:	 3366,	 3200	 (NH,	NH2),	 1664,	 1621	 (C=O).	 	 EI‐MS	
(m/z	 (%)):	515	(M++2,	1.9),	514	(M++1,	21.8),	468	(18.7),	422	
(3.5),	 394	 (2.8),	 288	 (4.4),	 243	 (71.7),	 225	 (81.1),	 215	 (77.8),	
178	(100),	170	(36.4),	150	(66.9),	142	(60.8),	122	(49.4),	115	
(33.8),	 90	 (31.9),	 77	 (67.4).	 Anal.	 calcd.	 for	 C25H27N3O5S2	 :C,	
58.46;	H,	5.30;	N,	8.18.	Found:	C,	58.40;	H,	5.36;	N,	8.13%.	
	
2.3.	Antioxidant	screening	
	
2.3.1.	Superoxide	anion	radical	scavenging	assay	
	
The	assay	was	performed	according	to	Nishmiki	et	al.	[19],	
with	minor	modifications.	 Test	 solution	 (0.1	mL,	 1	mg/mL	 of	
sample	 solution	 (DMSO))	 in	0.1	M	phosphate	buffer	 pH	=	7.4,	
62.5	µL	of	468	µM	NADH	solution,	62.5	µL	of	156	µM	nitroblue	
tetrazolium		(NBT)		solution		and		62.5		µL		of		60		µM	phenazine		
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Table	1.	Assay	for	superoxide	anion	radical	scavenging	and	Bleomycin‐dependent	DNA	damage	(DNA)	
Compound	no	 Antioxidant	activity	(Superoxide	anion	radical	scavenging,	%)	 Absorbance	of	samples	
Ascorbic	Acid	 66.1	 0.091	
1	 58.6	 0.078	
3	 48.6	 0.127	
4	 31.2	 0.080	
5	 35.7	 0.079	
6	 45.7	 0.113	
7	 61.4	 0.136	
8	 55.8	 0.125	
9	 41.4	 0.118	
10	 38.6	 0.157	
11	 10.3	 0.151	
12	 55.7	 0.102	
13	 6.1	 0.123	
14	 35.6	 0.145	
16	 58.9	 0.169	
17	 37.1	 0.134	
23	 57.1	 0.098	
24	 20.0	 0.100	
25	 18.6	 0.126	
*	All	compounds	were	dissolved	in	DMSO:MeOH	(1:1,	v:v)	and	tested	at	the	final	concentration	of	0.1	mL	of	1	mg/mL.	
	
 
Scheme	5	
	
	
methophosphate	 (PMS)	 solution	 were	 added	 to	 a	 microwell	
plate	 and	 incubated	 at	 room	 temperature	 for	 5	 min.	 and	 the	
abundance	 at	 560	 nm	 was	 measured	 against	 blank	 samples.	
The	capacity	of	scavenging	super	oxide	radicals	was	calculated	
using	the	following	formula:	
	
Scavenging	activity	=	[A	(control)	‐	A	(test)/	A	(control)]	×	100	 (1)	
	
The	 (NBT+NADH+PMS)	 solution	 without	 sample	 solution	
was	used	as	control.	
	
2.3.2.	Bleomycin‐dependent	DNA	damage	
	
The	assay	was	performed	according	to	Aeschlach	et	al.	[20],	
with	 minor	 modifications.	 The	 reaction	 mixture	 (0.5	 mL)	
contained	DNA	(0.5	mg/mL),	bleomycin	sulfate	(0.05	mg/mL),	
MgCl2	(5	mM),	FeCl3	(50	mM)	and	samples	to	be	tested	(0.1	mL	
of	 1	mg/mL).	 L‐Ascorbic	 acid	was	 used	 as	 a	 positive	 control.	
The	mixture	was	 incubated	at	37	°C	 for	1	h.	The	reaction	was	
terminated	by	addition	of	0.05	mL	EDTA	(0.1	M).	The	color	was	
developed	 by	 adding	 thiobarbituric	 acid	 (TBA)	 (0.5	mL)	 (1%,	
w:v)	and	HCl	(0.5	mL)	(25%,	v:v)	 followed	by	heating	at	80	°C	
for	10	min.	After	centrifugation,	the	extent	of	DNA	damage	was	
measured	by	the	increase	in	absorbance	at	532	nm	(Table	1).	
	
3.	Results	and	discussion		
	
3.1.	Chemistry	
	
Schemes	1‐4	describe	the	syntheses	of	the	target	molecules.	
The	 starting	 ethyl	 2‐[(cyanoacetyl)amino]‐4,5,6,7‐tetrahydro‐
1‐benzothiophene‐3‐carboxylate	3	[8]	was	prepared	according		
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Figure	1.	Structure	activity	relationship	of	the	more	potent	antioxidant	compounds.
	
	
to	 the	 previously	 reported	 method	 via	 refluxing	 of	 ethyl	 2‐
amino‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxylate	 (1)	
[17]	 with	 3‐(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)‐3‐oxopropane	
nitrile	(2)	[18].	
Multicomponent	 condensation	 of	 cyclopentanone	 or	 cyclo	
hexanone	 with	 compound	 3	 and	 elemental	 sulfur	 containing	
morpholine	as	a	catalyst	afforded	the	bithiophene	derivatives	4	
and	5,	respectively.	Compounds	4	and	5	form	hydrogen	bonds	
between	 carbonyl	 of	 esters	 and	 NH	 groups	 of	 amide	 and	
between	 amino	 groups	 and	 amidic	 groups.	 Because	 the	 IR	
spectra	revealed	 low	stretching	vibrations	of	ester	and	amidic	
carbonyl	groups	and	the	1H	NMR	spectra	show	the	presence	of	
NH	singlet	signal	at	11.04	and	11.10	ppm,	respectively,	similar	
behaviour	 was	 reported	 [21].	 Moreover,	 cyanoacetylation	 of	
compound	 4	 and	 5	 under	 the	 same	 previous	 conditions	
afforded	the	cyanoacetamide	derivatives	6	and	7.	Treatment	of	
compound	 7	 with	 cyclopentanone	 or	 cyclohexanone	 and	
elemental	sulfur	in	ethanol	containing	morpholine	afforded	the	
corresponding	 trithiophene	 derivatives	 8	 and	 9,	 respectively.	
Compound	8	and	9	formed	three	hydrogen	bonds	(Scheme	1).	
Knoevenagel	 condensation	 of	 compound	 7	 with	 4‐N,N‐
dimethylaminobezaldehyde,	 4‐piperdin‐1‐ylbenzaldehyde	 or	
salicyaldehyde	 in	 ethanol	 containing	 a	 catalytic	 amount	 of	
piperidine	 afforded	 the	 corresponding	 (E)	 arylidenes	 10,	 11	
and	coumarin	derivative	12,	respectively	[22]	(Scheme	2).		
Furthermore,	 condensation	 of	 compound	 3	 with	
terphthaldehyde	 in	 ethanol	 containing	 a	 catalytic	 amount	 of	
piperidine	 achieved	 the	 (E)	 bis‐arylidene	 derivative	 13	 [23].	
Coupling	 of	 compound	 3	 with	 benzene‐1,4‐bis(diazonium)	
dichloride	 afforded	 the	 (E)	 hydrazo	 derivative	 14	 [21]	
(Bioisostere	of	compound	13)	(Scheme	3).	
On	 the	 other	 hand,	 stirring	 of	 compound	 3	 with	 carbon	
disulphide	in	DMF	containing	potassium	hydroxide	followed	by	
in	 situ	 addition	 of	 ethyl	 bromoacetate	 afforded	 the	 triester	
derivative	 16	 via	 the	 intermediate	 15,	 which	 afforded	 the	
dithiophene	 17	 upon	 heating	 in	 DMF	 containing	 a	 catalytic	
amount	of	triethylamine	(Scheme	4).	
Attempting	 for	 preparation	 of	 compounds	 21	 and	 22,	
which	 were	 bioisostere	 of	 compound	 16	 via	 reaction	 of	
compound	 3	 with	 phenyl	 isothiocyanate	 in	 dry	 DMF	 in	 the	
presence	 of	 potassium	 hydroxide	 followed	 by	 addition	 of	
reaction	with	chloroacetone	or	ethyl	bromoacetate	was	 failed.	
Although	 both	 compound	 21	 and	 22	 were	 formed	 in	 situ,	
subsequently	 cyclized	 to	 the	 2‐{[(2Z)‐2‐cyano‐2‐(4‐methyl‐3‐
phenyl‐1,3‐thiazol‐2(3H)‐ylidene)acetyl]amino}‐4,5,6,7‐tetra	
hydro‐1‐benzothiophene‐3‐carboxylate	(19)	and	ethyl	2‐{[(2Z)	
‐2‐cyano‐2‐(4‐oxo‐3‐phenyl‐1,3‐thiazolidin‐2‐ylidene)acetyl]	
amino}‐4,5,6,7‐tetrahydro‐1‐benzothiophene‐3‐carboxylate	
(20),	 respectively	 [8].	 Acidification	 of	 the	 intermediate	
potassium	 salt	 15	 afforded	 compound	 23	 [8],	 refluxing	 of	
compound	 23	 with	 chloroacetone	 or	 ethyl	 bromoacetate	
afforded	 the	dithiophene	derivatives	24	 and	25	 (Bioisoster	of	
compound	17),	respectively	(Scheme	5).	The	structure	of	new	
synthesized	 compounds	was	 established	 on	 the	 basis	 of	 their	
elemental	analyses	and	spectral	data	(IR,	1H,	13C	NMR	and	mass	
spectral	data,	c.f.	Experimental	section).	
	
3.2.	Biological	Assays	
	
3.2.1.	Superoxide	anion	radical	scavenging	assay	
	
The	antioxidant	activity	of	the	new	synthesized	compounds	
was	evaluated	following	the	protocols	published	by	Nishimiki	et	
al.	 [19].	The	biological	data	showed	clearly	that	compounds	1,	
7,	8,	12,	16	and	23	have	good	activities,	while	compounds	3‐6,	
9,	10,	14	 and	17	 exhibited	moderate	 activities.	 On	 the	 other	
hand,	 the	 anther	 compounds	 exhibited	weak	 activities	 (Table	
1).	Thus,	 it	would	appear	 that	 introducing	of	 cyanoacetamide,	
thiocarbamoyl,	thiophene	and	coumarin	moieties	enhances	the	
antioxidant	properties	of	2‐aminothiophene	derivatives.	
All	 compounds	 were	 dissolved	 in	 DMSO:MeOH	 (1:1,	 v:v)	
and	tested	at	the	final	concentration	of	0.1	mL	of	1	mg/mL.	The	
extent	of	DNA	damage	 is	expressed	by	 increase	of	absorbance	
at	 520	 nm.	 The	 synthesized	 compounds	 were	 test	 for	
Bleomycin‐dependent	DNA	damage	(Table	1)	and	showed	that	
compounds	1,	4,	5,	12,	23	 and	24	 have	 an	 ability	 to	 protect	
DNA	from	the	induced	damage	by	Bleomycin.		
By	 comparing	 the	 results	 obtained	 of	 antioxidant	 of	 the	
compounds	 reported	 in	 this	 paper	 to	 their	 structures,	 the	
following	 structure	 activity	 relationship	 (SAR's)	 were	
postulated:		
(i) 2‐Aminothiophene	 derivatives	 1,	 4	 and	 5	 are	 more	
potent	than	ascorbic	acid	which	may	be	attributed	to	
the	 replacement	 of	 furan	moiety	with	 the	 thiophene	
moiety	and	presence	of	amino	group.	
(ii) Compounds	 3,	 6	 and	 7	 (N‐substituted‐2‐amino	
thiophene)	is	less	potent	than	compounds	1,	4	and	5,	
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respectively	which	may	be	due	to	decrease	of	basicity	
of	amino	group.		
(iii) Sulfanyl	 derivative	23	 is	 more	 potent	 than	3	 which	
may	 be	 attributable	 to	 presence	 of	 thiocarbamoyl	
moiety	or	may	be	due	to	oxidation	of	S‐H	 to	S‐S	and	
presence	of	further	conjugation.	
(iv) Compounds	 12	 and	 24	 exhibited	 high	 antioxidant	
activity	 which	 may	 be	 due	 presence	 of	 imino	
coumarin	and	3‐aminothiophene	moiety	(Figure	1).	
	
4.	Conclusion	
	
The	 objective	 of	 the	 present	 study	was	 to	 synthesize	 and	
evaluate	 the	antioxidant	 activity	of	 some	novel	bis‐thiophenes	
with	 the	 hope	 of	 discovering	 new	 structure	 leads	 serving	 as	
antioxidant	agents.	The	data	clearly	showed	that	compounds	1,	
7,	8,	12,	16	 and	23	 have	 good	 activities	 exhibited	weak	 anti‐
oxidant	activities	by	Superoxide	anion	radical	scavenging	assay.	
On	the	other	hand,	compounds	1,	4,	5,	12,	23	and	24	have	an	
ability	to	protect	DNA	from	the	induced	damage	by	Bleomycin.		
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